NCT06785246 (Grasshopper) is a NA clinical trial of Grasshopper dashboard in Chest Infection, sponsored by Kaiser Permanente.

Who is sponsoring NCT06785246?

NCT06785246 is sponsored by Kaiser Permanente.

What drugs are being tested in NCT06785246?

Interventions in NCT06785246: Grasshopper dashboard.

What condition does NCT06785246 study?

NCT06785246 studies Chest Infection, Pulmonary Edema - Acute.

Is NCT06785246 still recruiting?

NCT06785246 is currently enrolling by invitation. Last updated 21 January 2025.

Last reviewed 2025-01-21 · How we verify

NCT06785246: Grasshopper

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Grasshopper: a Novel Clinical Dashboard for Radiologists

ENROLLING BY INVITATION NA Last updated 21 January 2025

What this trial tests

NA trial testing Grasshopper dashboard in Chest Infection in 100,000 participants. Enrolling by invitation.

Timeline

1 January 2024

Primary endpoint
31 December 2025

31 December 2025

Quick facts

Lead sponsor	Kaiser Permanente
Phase	NA
Status	ENROLLING BY INVITATION
Study type	INTERVENTIONAL
Allocation	na
Design	sequential
Masking	none
Primary purpose	other
Enrollment	100,000
Start date	1 January 2024
Primary completion	31 December 2025
Estimated completion	31 December 2025
Sites	1 location across United States

Drugs / interventions tested

Grasshopper dashboard

Conditions studied

Chest Infection — all drugs for Chest Infection →
Pulmonary Edema - Acute — all drugs for Pulmonary Edema - Acute →

Sponsor

Kaiser Permanente — full company profile →

Who can join

Eligibility, any sex, with Chest Infection or Pulmonary Edema - Acute. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Does a radiology clinical dashboard increase radiologist use of specific reporting language for chest X-rays (CXRs) and thereby decrease rates of unnecessary Emergency Department (ED) prescriptions and follow-up imaging?

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Kaiser Permanente trials

Trials by the same sponsor.

NCT07522645 — Adherence to Dyslipidemia Therapy: Harnessing Evidence From Randomized Evaluations in AtheroSclerotic CardioVascular Dis · NA · not yet recruiting
NCT07474038 — AI-Supported Cognitive Rehabilitation for Older Adults With Mild Cognitive Impairment · NA · enrolling by invitation
NCT07467668 — Infusing Needed Iron to Target Insufficiency in Adults Treated for Evidence of Heart Failure · NA · not yet recruiting
NCT07216859 — Screening Cardiometabolic Opportunities Using Transformative Echocardiography Artificial Intelligence (SCOUT Echo-AI) · NA · not yet recruiting
NCT07264062 — MetSense Pilot and Feasibility · NA · enrolling by invitation

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06785246 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Kaiser Permanente
Last refreshed: 21 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06785246.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing